United Therapeutics Corporation

UTHR · NASDAQ
Analyze with AI
$517.13+$10.13 (+2%)
At close:Dec 19, 2025, 9:00 PM UTC
$517.13+$0.00 (+0%)
After hours:Dec 19, 2025, 11:07 PM UTC
P/E TTM17.81
P/B TTM3.44
P/S TTM7.38
Dividend Yield0%
EPS$26.36
Beta0.861
Valuation
PEG Ratio6.17
FCF Yield4.86%
EV / EBITDA12.75
Quality
ROIC16.75%
Gross Margin88.59%
Cash Conv. Ratio1.22
Growth
Revenue 3Y CAGR14.11%
FCF Growth44.54%
Safety
Net Debt / EBITDA-0.79
Interest Coverage61.46
Efficiency
Inventory Turnover2.02
Cash Conv. Cycle-263.38

United Therapeutics Corporation (UTHR) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is United Therapeutics Corporation (UTHR) stock price today?

As of Dec 19, 2025, 9:00 PM UTC, United Therapeutics Corporation (UTHR) stock is trading at $517.13. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date UTHR stock quotes for informed trading decisions.

What is United Therapeutics Corporation's market capitalization?

United Therapeutics Corporation (UTHR) has a market capitalization of approximately $23.1B. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare United Therapeutics Corporation's size relative to other companies in the USD market. The market cap figure updates automatically as the UTHR stock price changes.

What is the 52-week range for United Therapeutics Corporation stock?

United Therapeutics Corporation (UTHR) stock has traded in a 52-week range of $266.98 — $518.61. The 52-week range shows the highest and lowest prices at which UTHR traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current United Therapeutics Corporation stock price to this range provides context for recent price action.

How much trading volume does United Therapeutics Corporation stock have?

United Therapeutics Corporation (UTHR) stock recently traded approximately 1.5M shares. Trading volume indicates market liquidity and investor interest in UTHR. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting United Therapeutics Corporation stock.

Does United Therapeutics Corporation pay dividends to shareholders?

Yes, United Therapeutics Corporation (UTHR) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate United Therapeutics Corporation stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is United Therapeutics Corporation's intraday price range?

Today, United Therapeutics Corporation (UTHR) stock has traded in a range of $503.70 — $518.18. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring UTHR's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get United Therapeutics Corporation stock data?

AlphaPilot sources real-time UTHR stock quotes, fundamental financial data, and historical price charts for United Therapeutics Corporation from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The United Therapeutics Corporation stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of UTHR stock performance.